Advertisement

Toxicological Review of Methyl- and Ethyl-tertiary-Butyl Ethers

  • Douglas McGregor
Part of the The Handbook of Environmental Chemistry book series (HEC)

Abstract

Metabolism and kinetic studies have shown that the overall elimination of ETBE and MTBE from blood in volunteers was multiphasic, (two or four phases in the case of ETBE and two or three phases for MTBE). The half-lives varied in different experiments and ranged from a few minutes for early phases up to a terminal half-life of 33 h in one experiment each with ETBE and MTBE. The kinetic data obtained from experiments with rats exposed to ETBE are restricted to a statement that the apparent half-life of elimination of ETBE from blood is about 0.8 h, but it is not clear if this only refers to an initial half-life. Some guidance may be possible from the known behaviour of MTBE. Its elimination from rat blood appears to be biphasic, with an initial half-life of less than 1 h and second half-lives ranging from 37 h to 92 h (reviewed in McGregor 2006). Elimination occurs in exhaled air (mainly unchanged ethers) and urine (metabolites). The main circulating metabolite is TBA formed by oxidation of ethers by cytochrome isoenzymes, while the main urinary metabolites are 2-hydroxyisobutyrate and 2-methyl-1,2-propanediol. The half-life of TBA in the blood of volunteers exposed to the ethers is about 8 to 12 h. Comparable measurements have not been made in rodents. Exposure of volunteers to the ethers at concentrations of up to 25 or 50 ppm (106 or 212 mg/m3) for 2h produced a slight impairment (3.2 to 4.4%) in pulmonary function, but other measures and subjective reports show little effect of exposure. Non-human experimental studies have not revealed significant general toxicity, neurotoxicity, toxicity to reproduction or genotoxicity. Neither MTBE nor ETBE is acutely toxic following oral, dermal or inhalation administration or an eye irritant, while MTBE, but not ETBE is considered to be a skin irritant. Sensitisation has not been demonstrated with either compound in guinea-pig maximisation tests.

Other studies of systemic toxicity of MTBE and ETBE were largely restricted to a nephropathy in male rats that was associated with the accumulation of hyaline droplets that immunohistochemically stained for α2u-globulin. Apparently, the same type of nephropathy occurs in TBA-treated rats. In addition, MTBE exposure during a two-year study in rats led to exacerbation in males of the spontaneously occurring chronic progressive nephropathy (CPN), even to the most severe or “end-stage” in some cases. The effects of MTBE, ETBE and TBA on renal tubule cells are weak, specific to male rats, and not observed in mice of either sex. They are not necessarily due to metabolically generated TBA alone, although this metabolite, which is common to both ethers, does persist in the blood of rats at higher concentrations and for a longer time than the parent ethers. In vitro studies with MTBE demonstrated its specific binding to kidney proteins from male rats and that it interacts with α2u-globulin. Under the conditions of these experiments, metabolism of MTBE to TBA was not likely to be significant. It is reasonable to predict that similar experiments with ETBE would produce similar results. The available data on ETBE are not extensive, but they support the hypothesis that the mode of action is dependent on α2u-globulin nephropathy, which is widely considered to be of no human relevance. In CD-1 mice of both sexes there was a minimal renal nephropathy, but this occurred in all groups, including controls, at frequencies that varied between 27% and 64% with little indication of a dose-response relationship. It is unlikely to have been caused by ETBE treatment. The only other effect of note was treatment-associated bone marrow congestion in female rats exposed to 1750 ppm (7420 mg/m3) ETBE for 3 months. There was no accompanying effect on the haematopoietic cell population, and an increase in mean corpuscular volume was not considered clinically relevant. No similar effect was reported for male rats or for mice of either sex.

With regard to carcinogenicity, low incidences of renal tubule cell adenomas were found in male rats treated with MTBE. This effect appears to be associated with exacerbation of CPN to end-stage as well as α2u-globulin nephropathy induction. Both conditions are male rat specific. TBA also induces adenomas of the renal tubule cells and this response is also associated with α2u-globulin nephropathy. Neither of the conditions predisposing to renal tubule cell neoplasia has human relevance. ETBE has not been tested for carcinogenicity, but results from short-term studies suggest that it would also induce kidney tumours by the same modes of action as MTBE.

Thyroid follicular cell adenomas were increased in female mice treated with TBA, but this result lacks any independent supporting evidence from a number of studies in mice and rats. There was no evidence for a hepatic effect of TBA within this mouse carcinogenicity study; therefore, no internal evidence exists for a hormonal mechanism of thyroid follicular cell induction. No thyroid neoplasms were increased in the carcinogenicity studies of MTBE.

Keywords

Leydig Cell Methyl Tert Butyl Ether Inhalation Exposure Methyl Tertiary Butyl Ether Ethyl Tertiary Butyl Ether 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Scholz B, Butzert H, NeumeisterJ, Nierlich F (1990) Methyl tert-butyl ether. In: Elvers B, Hawkins S, Schulz G (eds) Ullmann’s Encyclopedia of Industrial Chemistry, 5th rev Ed, vol A16. Wiley, New York, pp 543–550Google Scholar
  2. 2.
    IARC (1999a) IARC Monographs on the Evaluation of Carcinogenic Risks to Hu-mans, vol 73, Some Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances. IARC Press, Lyon, p 674Google Scholar
  3. 3.
    EU (2002) European Union Risk Assessment Report Vol. 19: Tert-Butyl Methyl Ether. CAS. No. 1634-04-4. EINECS No. 216-653-1. Final Report. Office for Official Publications of the European Communities, Luxembourg, p 292Google Scholar
  4. 4.
    CruzanG , Borghoff SJ, de Peyster A, Hard GC, McClainM , McGregor DB, Thomas MG (2006) Methyl tertiary–butyl ether mode of action for cancer endpoints in rodents. Reg Toxicol Pharmacol 47:156–165CrossRefGoogle Scholar
  5. 5.
    McGregor D (2006) Methyl tertiary-butyl ether: studies for potential human health hazards. Crit Rev Toxicol 36:319–358CrossRefGoogle Scholar
  6. 6.
    McGregor D (2007) Ethyl tertiary-Butyl Ether: a Toxicological Review. Crit Rev Tox-icol 37:1–26CrossRefGoogle Scholar
  7. 7.
    Hong J-Y, Yang CS, Lee M, Wang Y-Y, Huang W-Q, Tan Y, Patten CJ, Bondoc FY (1997a) Role of cytochromes P-450 in the metabolism of methyl tert-butyl ether in human livers. Arch Toxicol 71:266–269CrossRefGoogle Scholar
  8. 8.
    Hong J-Y, Wang Y-Y, Bondoc FY, Lee M, Yang CS, Hu W-Y, Pan J (1999a) Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterogologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst. Toxicol Appl Pharmacol 160:43–48CrossRefGoogle Scholar
  9. 9.
    Hong J-Y, Wang Y-Y, Mohr SN, Bondoc FY, Deng C (2001) Human cytochrome P-450 isozymes in metabolism and health effects of gasoline ethers. Health Effects Institute Report No. 102, pp 7–27Google Scholar
  10. 10.
    Le Gal A, Dreano Y, Gervasi PG, Berthou F (2001) Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels. Toxicol Lett 124:47–58CrossRefGoogle Scholar
  11. 11.
    Amberg A, Rosner E, Dekant W (2000) Biotransformation and kinetics of excretion of ethyl-tert-butyl ether in rats and humans. Toxicol Sci 53:194–201CrossRefGoogle Scholar
  12. 12.
    Liebach HM, Forst C (1984) Hydroxycarboxylic and oxocarboxylic acids in urine: Products from branch-chain amino acid degradation and from ketogenesis. J Chromatogr 309:225–242CrossRefGoogle Scholar
  13. 13.
    BernauerU , Amberg A, Schentow D, Dekant W (1998) Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatograohy/mass spectrometry. Chem Res Toxicol 11:651–658CrossRefGoogle Scholar
  14. 14.
    Heck H d’A, White EL, Casanova-Schmitz M (1982) Determination of formaldehyde in biological tissues by gas chromatography/mass spectrometry. Biomed Mass Spectrom 9:347–353CrossRefGoogle Scholar
  15. 15.
    Heck H d’A, Casanova-Schmitz M, Dodd PB, Schachter EN, Witek TJ, Tosun T (1985) Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am Ind Hyg Assoc J 46:1–3CrossRefGoogle Scholar
  16. 16.
    Uotila L, Koivusalo M (1974) Formaldehyde dehydrogenase from human liver. Purifi-cation, properties, and evidence for the formation of glutathione thiol esters by the enzyme. J Biol Chem 249:7653–7663Google Scholar
  17. 17.
    Koivusalo M, Baumann M, Uotila L (1989) Evidence for the identity of glutathione- dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase. FEBS Lett 257:105–109CrossRefGoogle Scholar
  18. 18.
    Uotila L, Koivusalo M (1997) Expression of formaldehyde dehydrogenase and S-formylglutathione hydrolase activities in different rat tissues. Adv Exp Med Biol 414:365–371CrossRefGoogle Scholar
  19. 19.
    Hatake K, Taniguchi T, Ouchi H, Sakaki N, Hishida S, Ijiri I (1990) Possible involve-ment of kinins in cardiovascular changes after alcohol intake. Pharmacol Biochem Behav 35:437–442CrossRefGoogle Scholar
  20. 20.
    Lieber CS (1988) Metabolic effects of acetaldehyde. Biochem Soc Trans 16:241–247Google Scholar
  21. 21.
    Lynch C, Lim CK, Thomas M, Peters TJ (1983) Assay of blood and tissue aldehydes by HPLC analysis of their 2,4-dinitrophenulhydrazine adducts. Clin Chim Acta 130:117–122CrossRefGoogle Scholar
  22. 22.
    Klyosov A A, Rashkovetsky LG, TahirMK, KeungW-M (1996) Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. Biochemistry 35:4445–4456CrossRefGoogle Scholar
  23. 23.
    Rashkovetsky LG, Maret W, Klyosov AA (1994) Human liver aldehyde dehydrogenases: new method of purification of the major mitochondrial and cytosolic enzymes and re-evaluation of their kinetic properties. Biochim Biophys Acta 1205:301–307Google Scholar
  24. 24.
    Zorzano A, Herrera E (1990) Differences in the kinetic properties and sensitivity to inhibitors of human placental, erythrocyte, and major hepatic aldehyde dehydroge-nase isoenzymes. Biochem Pharmacol 39:873–878CrossRefGoogle Scholar
  25. 25.
    Nihlen A, LofA, Johanson G (1998a) Experimental exposure to methyl tert-butyl ether: Toxicokinetics in humans. Toxicol Appl Pharmacol 148:274–280CrossRefGoogle Scholar
  26. 26.
    Lee C-W, Mohr SN, Weisel CP (2001) Toxicokinetics of human exposure to methyl tertiary-butyl ether (MTBE) following short-term controlled exposures. J Exp Anal Environ Epidemiol 11:67–78CrossRefGoogle Scholar
  27. 27.
    Dekant W, BernauerU, Rosner E, Amberg A (2001a) Biotransformation of MTBE, ETBE and TAME after inhalation or ingestion in rats and humans. Health Effects Institute Report No. 102 (May 2001), pp 29–71Google Scholar
  28. 28.
    Prah J, Ashley D, Blount B, Case M, Leavens T, Pleil J, Cardinali F (2004) Dermal, oral, and inhalation pharmacokinetics of methyl tertiary butyl ether (MTBE) in human volunteers. Toxicol Sci 77:195–205CrossRefGoogle Scholar
  29. 29.
    White MC, Johnson CA, Ashley DL, Buchta TM, PelletierDJ (1995) Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health 50:183–189CrossRefGoogle Scholar
  30. 30.
    Cain WS, Leaderer BP, Ginsberg GL, Andrews LS, Cometto-Muniz JE, Gent JF, Buck M, Berglund LG, Mohsenin V, Monahain E, Kjaergaard S (1996) Acute exposure to low-level methyl tertiary-butyl ether (MTBE): Human reactions and pharmacokinetic response. Inhal Toxicol 8:21–48CrossRefGoogle Scholar
  31. 31.
    Buckley TJ, Prah JD, Ashley D, Zweidinger RA, Wallace LA (1997) Body burden measurements and models to assess inhalation exposure to methyl tertiary butyl ether (MTBE). J Air Waste Manage Assoc 47:739–752CrossRefGoogle Scholar
  32. 32.
    Lee C-W, Weisel CP (1998) Determination of methyl tert-butyl ether and tert-butyl alcohol in human urine by high-temperature purge-and-trap gas chromatographymass spectrometry. J Anal Toxicol 22:1–5CrossRefGoogle Scholar
  33. 33.
    Leuschner U, Hellstern A, Schmidt K, Fischer H, Guldutuna S, Hubner K, Leuschner M (1991) Gallstone dissolution with methyl tert-butyl ether in 120 patients— Efficacy and safety. Dig Dis Sci 36:193–199CrossRefGoogle Scholar
  34. 34.
    Moolenaar RL, Hefflin BJ AshelyDL, Middaugh JP, Etzel RA (1994) Methyl tertiary butyl ether in human blood after exposure to oxygenated fuel in Fairbanks, Alaska. Arch Environ Health 49:402–409CrossRefGoogle Scholar
  35. 35.
    Nihlen A, Lof A, Johanson G (1998c) Controlled ethyl tert-butyl ether (ETBE) expo-sure of male volunteers (i) toxicokinetics. Toxicol Sci 46:1–10Google Scholar
  36. 36.
    Imbriani M, Ghittori S, Pezzagno G (1997) Partition coefficients of methyl tert-butyl ether (MTBE). G Ital Med Lav Ergon 19:63–65Google Scholar
  37. 37.
    Nihlen A, Lof A, Johanson G (1995) Liquid/air partition coefficients of methyl and ethyl t-butyl ethers, t-amyl methyl ether, and t-butyl alcohol. J Exp Anal Environ Epidemiol 5:573–582Google Scholar
  38. 38.
    Dekant W, Bernbauer U, Rosner E, Amberg A (2001b) Toxicokinetics of ethers used as fuel oxygenates. Toxicol Lett 124:37–45CrossRefGoogle Scholar
  39. 39.
    Amberg A, Rosner E, Dekant W (1999) Biotransformation and kinetics of excretion of methyl-tert-butyl ether in rats and humans. Toxicol Sci 51:1–8CrossRefGoogle Scholar
  40. 40.
    CedarbaumAI , Qureshi A, Cohen G (1980) Production of formaldehyde and acetone by hydroxyl-radical generating systems during the metabolism of tertiary butyl alcohol. Biochem Pharmacol 32:3517–3524CrossRefGoogle Scholar
  41. 41.
    Brady JF, Xiao F, Ning SM, Yang CS (1990) Metabolism of methyl tertiary-butyl ether by rat hepatic microsomes. Arch Toxicol 64:157–160CrossRefGoogle Scholar
  42. 42.
    Savolainen H, Pfaffli P, ElovaaraE (1985) Biochemical effects of methyl tertiary-butyl ether in extended vapour exposure of rats. Arch Toxicol 57:285–288CrossRefGoogle Scholar
  43. 43.
    TuriniA , Amato G, Longo V, Gervasi PG (1998) Oxidation of methyl- and ethyl- tertiary-butyl ethers in rat liver microsomes: role of the cytochrome P-450 isoforms. Arch Toxicol 72:207–214CrossRefGoogle Scholar
  44. 44.
    Hong J-Y, Wang Y-Y, Bondoc FY, Yang CS, Gonzalez FJ, Pan Z, Cokonis C-D, Hu W-Y, Bao Z (1999b) Metabolism of methyl tert-butyl ether and other gasoline ethers in mouse liver microsomes lacking cytochrome P450 2E1. Toxicol Lett 105:83–88CrossRefGoogle Scholar
  45. 45.
    Hong J-Y, Wang Y-Y, Bondoc FY, Yang CS, Lee M, Huang W-Q (1997b) Rat olfactory mucosa displays a high activity in metabolising methyl tert-butyl ether and other gasoline ethers. Fund Appl Toxicol 40:205–210CrossRefGoogle Scholar
  46. 46.
    Casanova M, d’A Heck H (1997) Lack of evidence for the involvement of formalde-hyde in the hepatocarcinogenicity of methyl tertiary butyl ether in CD-1 mice. Chem-Biol Interactions 105:131–143CrossRefGoogle Scholar
  47. 47.
    Miller MJ, Ferdinandi ES, Klan M, Andrews LS, Douglas JF, Kneiss JJ (1997) Pharma-cokinetics and disposition of methyl t-butyl ether in Fischer-344 rats. J Appl Toxicol 17:(Suppl1):3–12CrossRefGoogle Scholar
  48. 48.
    Sun JD, Beskitt JL (1995a) Ethyl tertiary-butyl ether (ETBE) pharmacokinetics after single and repeated inhalation exposure of rats. Bushy Run Research Center Project 94N1454. Unpublished study for ARCO Chemical Company, 19 June 1995Google Scholar
  49. 49.
    Sun JD, Beskitt JL (1995b) Ethyl tertiary-butyl ether (ETBE) pharmacokinetics after single and repeated inhalation exposure of mice. Bushy Run Research Center Project 94N1455. Unpublished study for ARCO Chemical Company, 19 June 1995Google Scholar
  50. 50.
    Borghoff SJ, Ashgarian B (1996) Ethyl tertiary-butyl ether (ETBE): Pharmacokinetic study in male and female CD-1 mice after single inhalation exposure and male and female F-344 rats after single and repeated inhalation exposure. CIIT Protocol 95026. Unpublished study for ARCO Chemical Company, 19 December 1996Google Scholar
  51. 51.
    Borghoff SJ, Murphy JE, Medinsky MA (1996) Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats. Fundam Appl Toxicol 30:264–275CrossRefGoogle Scholar
  52. 52.
    Borghoff SJ, Short BG, Swenberg JA (1990) Biochemical mechanisms of pathology of alpha2uglobulin nephropathy. Ann Rev Pharmacol Toxicol 30:349–367CrossRefGoogle Scholar
  53. 53.
    YoshikawaM , Arashidani K, KatohT , Kawamoto T, KodamaY (1994) Pulmonary elimination of methyl tertiary-butyl ether after intraperitoneal administration in mice. Arch Toxicol 68:517–519CrossRefGoogle Scholar
  54. 54.
    Poet TS, Borghoff SJ (1997) In vitro uptake of methyl tert-butyl ether in male rat kid-ney: use of a two-compartment model to describe protein interactions. Toxicol Appl Pharmacol 145:340–348CrossRefGoogle Scholar
  55. 55.
    Fiedler N, Kelly-McNeil K, Mohr S, Lehrer P, Opiekun RE, Lee C, Wainman T, Hamer R, Weisel C, Edelberg R, Lioy PJ (2000) Controlled human exposure to methyl tertiary butyl ether in gasoline: symptoms, psychophysiologic and neurobehavioral responses of self-reported sensitive persons. Environ Health Perspect 108:753–763CrossRefGoogle Scholar
  56. 56.
    Prah JD, Goldstein GM, Devlin R, Otto D, Ashley D, House D, Cohen KL, Gerrity T (1994) Sensory, symptomatic, inflammatory, and ocular responses to and the metabolism of methyl tertiary butyl ether in a controlled human exposure experi-ment. Inhal Toxicol 6:521–538CrossRefGoogle Scholar
  57. 57.
    Nihlen A, Walinder R Lof A, Johanson G (1998b) Experimental exposure to methyl tertiary-butyl ether. Toxicol Appl Pharmacol 148:281–287CrossRefGoogle Scholar
  58. 58.
    Fiedler N, Kipen HM (2001) Controlled exposures to volatile organic compounds in sensitive groups. Ann NY Acad Sci 933:24–37CrossRefGoogle Scholar
  59. 59.
    Nihlén A, Lof A, Johanson G (1998d) Controlled ethyl tert-butyl ether (ETBE) expo-sure of male volunteers (ii) acute effects. Toxicol Sci 46:143–150Google Scholar
  60. 60.
    MB Research Laboratories (1988a) Test article: ethyl tertiary butyl ether; single dose oral toxicity in rats/LD50 in rats. Unpublished report MB88-9137A for ARCO Chem-ical Company, PAGoogle Scholar
  61. 61.
    MB Research Laboratories (1988b) Test substance: ethyl tertiary butyl ether; acute dermal toxicity in rabbits/LD50 in rabbits. Unpublished report MB 88-9107 B for ARCO Chemical Company, PAGoogle Scholar
  62. 62.
    IIT Research Institute (1989a) Acute dermal toxicity study of ethyl-tert-butyl ether (ETBE) in rabbits. Unpublished study L3100 for Amoco Corporation, September 1989Google Scholar
  63. 63.
    IIT Research Institute (1989b) Acute inhalation toxicity study of ethyl-t-butyl ether (ETBE) in rats. Unpublished Report 1496 for Amoco Corporation, November 1989Google Scholar
  64. 64.
    Institut Pasteur de Lille (1992a) Etude de toxicité aigue aux doses limites (selon CEE annexe VIJ 08-7-92) par voie orale chez le rat: Ether ETBE. Unpublished report IPL- R 920607 for Total Raffinage Distribution, 18 June 1992Google Scholar
  65. 65.
    Pharmakon Europe (1994a) Test article: ETBE. Test to evaluate the acute toxicity fol-lowing a single oral administration (limit test) in the rat. Unpublished report No 76493 for Elf, 17 March 1994Google Scholar
  66. 66.
    ARCO (1980) Methyl Tertiary Butyl Ether: Acute Toxicological Studies. ARCO Chemical Company, Glenolden, PennsylvaniaGoogle Scholar
  67. 67.
    Cuthbert JA (1979) Safety Tests on Methyl tert-butyl ether. Inveresk Research Inter-national, EdinburghGoogle Scholar
  68. 68.
    Mastri C, Keplinger ML, Fancher OE (1969) Acute Toxicity Studies on X-801-25. In-dustrial Bio-test Laboratories (IBT), Northbrook, IllinoisGoogle Scholar
  69. 69.
    RBM (1992b) Acute eye irritation study in New Zealand White rabbits treated with test article MTBE. Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A, Rome, ItalyGoogle Scholar
  70. 70.
    MB Research Laboratories (1988c) Test substance: ethyl tertiary butyl ether; eye ir-ritation in rabbits. Unpublished study MB 88-9107 D for ARCO Chemical Company, PAGoogle Scholar
  71. 71.
    Centre International de Toxicologie (1992a) Ether irritation oculaire aigue chez le lapin, Etude No. 8930 TAL for Total Raffinage Distribution, 26 August 1992Google Scholar
  72. 72.
    Pharmakon Europe (1994b) Test article: ETBE. Test to evaluate the acute ocular ir-ritation and reversibility in the rabbit (3 animals). Report No 76293 for Elf, 1 April 1994Google Scholar
  73. 73.
    Mürmann P (1985) Prüfung der akuten Hautreizwirkung von Driveron (MTB): Hüls, MarlGoogle Scholar
  74. 74.
    RBM (1992a) Acute dermal irritation study in New Zealand White rabbits treated with test article MTBE. Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A, Rome, ItalyGoogle Scholar
  75. 75.
    RBM (1996a) Acute dermal irritation study in New Zealand White rabbits treated with the test article MTBE. Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A, Rome, ItalyGoogle Scholar
  76. 76.
    MB Research Laboratories (1988d) Test substance ethyl tertiary butyl ether. Primary Dermal Irritation in rabbits. Unpublished report MB 88-9107C for ARCO Chemical Company, PAGoogle Scholar
  77. 77.
    Centre International de Toxicologie (1992b) Ether effet irritant aigu sur la peau chez le lapin. Etude No. 8929 TAL for Total Raffinage Distribution, 26 August 1992Google Scholar
  78. 78.
    Pharmakon Europe (1994c) Test article: ETBE. Test to evaluate the acute primary cu-taneous irritation and corrosivity in the rabbit (3 animals). Report No 78193 for Elf, 1 April 1994Google Scholar
  79. 79.
    Litton Bionetics (1980a) Guinea Pig Sensitization Study: TBME-99. Litton Bionetics, Kensington, MarylandGoogle Scholar
  80. 80.
    Pharmakon Europe (1994d) Test article: ETBE. Test to evaluate sensitising potential in the guinea pig. Report No 76393 for Elf, 29 April 1994Google Scholar
  81. 81.
    White RD, Daughtrey WC, Wells MS (1995) Health effects of inhaled tertiary amyl methyl ether and ethyl tertiary butyl ether. Toxicol Lett 82/83:719–724CrossRefGoogle Scholar
  82. 82.
    MedinskyMA , Wolf DC, CattleyRC , Wong B, Janszen DB, Farris GM, Wright GA, Bond JA (1999) Effects of a thirteen-week inhalation exposure to ethyl tertiary butyl ether on Fischer-344 rats and CD-1 mice. Toxicol Sci 51:108–118CrossRefGoogle Scholar
  83. 83.
    BondJA , MedinskyMA , Wolf DC, Dorman DC, CattleyR , Farris G, Wong B, Morgan K, Janszen D, Turner MJ, Sumner SCJ (1996a) Ethyl tertiary butyl ether (ETBE): ninety-day vapor inhalation toxicity study with neurotoxicity evaluations in Fischer 344 rats. CIIT Project ID 95029, unpublished study for ARCO Chemical Company, PA, USAGoogle Scholar
  84. 84.
    Bond JA, Medinsky MA, Wolf DC, CattleyR, Farris G, Wong, Janszen D, Turner MJ, Sumner SCJ (1996b) Ethyl tertiary butyl ether (ETBE): ninety-day vapor inhalation toxicity study CD-1 mice. CIIT Project ID 95030, unpublished study for ARCO Chemical Company, PA, USAGoogle Scholar
  85. 85.
    Greenough RJ, McDonald P, Robinson P, Cowie JR, Maule W, MacNaughton F, Rushton A (1980) Methyl Tertiary Butyl Ether (Driveron) Three Month Inhalation Toxicity in Rats, p 227. Inveresk Research International, Tranent, ScotlandGoogle Scholar
  86. 86.
    Robinson M, Bruner RH, Olson GR (1990) Fourteen- and ninety-day oral toxicity studies of methyl tertiary-butyl ether in Sprague-Dawley rats. J Am Coll Toxicol 9:525–540CrossRefGoogle Scholar
  87. 87.
    Daughtrey WC, Gill MW, Pritts IM, Douglas JF, Kneiss JJ, Andrews LS (1997) Neurotoxicological evaluation of methyl tertiary-butyl ether in rats. J Appl Toxicol 17:57–64CrossRefGoogle Scholar
  88. 88.
    Dorman DC, Struve MF, Wong BA, Morgan KT, Janszen DB, Gross EB, BondJA (1997) Neurotoxicological evaluation of ethyl tertiary–butyl ether following subchronic (90-day) inhalation in the Fischer 344 rat. J Appl Toxicol 17:235–242CrossRefGoogle Scholar
  89. 89.
    Gaoua W (2003) Ethyl tertiarybutyl ether (ETBE), CAS No. 637-92-3: Reproduction/developmental toxicity dose-range finding/probe study by the oral (gavage) route in two strains of rat. CIT Study No. 24168 RSR, unpublished study for Total- finaelf on behalf of the ETBE Producers’ Consortium, 2 October 2003Google Scholar
  90. 90.
    Gaoua W (2004a) Ethyl tertiary butyl ether (ETBE): Prenatal developmental toxicity study by the oral route (gavage) in rats. CIT Study No. 24860 RSR, unpublished study for Totalfinaelf on behalf of the ETBE Producers’ ConsortiumGoogle Scholar
  91. 91.
    Gaoua W (2004b) Ethyl tertiary butyl ether (ETBE): Two-generation study (repro-duction and fertility effects) by the oral route (gavage) in rats. CIT Study No. 24859 RSR, unpublished study for Totalfinaelf on behalf of the ETBE Producers’ Consor-tiumGoogle Scholar
  92. 92.
    Mueller RA (1996) General anesthetic drugs. In: Munson PL, Mueller RA, Breese GR (eds) Principles of Pharmacology. Chapman and Hall, New York, pp 227–242Google Scholar
  93. 93.
    Chun JS, Burleigh-Flayer HD, KintighWJ (1992) Methyl Tertiary Butyl Ether: Vapor Inhalation Oncogenicity Study in Fischer 344 Rats. Bushy Run Research Center Export, PennsylvaniaGoogle Scholar
  94. 94.
    Bird MG, Burleigh-Flayer HD, Chun JS, Douglas JF, Kneiss JJ, Andrews LS (1997) Oncogenicity studies of inhaled methyl tertiary-butyl ether (MTBE) in CD-1 mice and F-344 rats. J Appl Toxicol 17:45–55CrossRefGoogle Scholar
  95. 95.
    Belpoggi F, Soffritti M, Maltoni C (1995) Methyl-tertiary-butyl ether (MTBE)— a gasoline additive—causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Health 11:119–149Google Scholar
  96. 96.
    Belpoggi F, Soffritti M, Filipinni F, Maltoni C (1997) Results of long-term experi-mental studies on the carcinogenicity of methyl tert-butyl ether. Ann NY Acad Sci 837:77–95CrossRefGoogle Scholar
  97. 97.
    Belpoggi F, Soffritti M, Maltoni C (1998) Pathological characterization of testicular tumours and lymphomas-leukaemias, and of their precursors observed in Sprague- Dawley rats exposed to methyl-tertiary-butyl-ether (MTBE). Eur J Oncol 3:201–206Google Scholar
  98. 98.
    NTP National Toxicology Program (1995) Toxicology and Carcinogenesis Studies of t-Butyl Alcohol in F344/N Rats and B6C3F1 Mice (Tech Rep Ser No 436; NIH Publ No. 95-3167), Research Triangle Park, NCGoogle Scholar
  99. 99.
    Cirvello JD, RadovskyA, Heath JE, Farnell DR, Lindamood C (1995) Toxicity and carcinogenicity of t-butyl alcohol in rats and mice following chronic exposure in drinking water. Toxicol Ind Health 11:151–165Google Scholar
  100. 100.
    Lington AW, Dodd DE, Ridlon SA, Douglas JF, Kneiss JJ, Andrews LS (1997) Evaluation of 13-week inhalation toxicity study on methyl t-butyl ether (MTBE) in Fischer 344 rats. J Appl Toxicol 17(1):37–44CrossRefGoogle Scholar
  101. 101.
    Prescott-Mathews JS, Wolf DC, Wong BA, Borghoff SJ (1997) Methyl tert-butyl ether causes a2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats. Toxicol Appl Pharmacol 143:301–314CrossRefGoogle Scholar
  102. 102.
    IITRI (1992) 28 day oral (gavage) toxicity study of methyl tert-butyl ether (MTBE) in rats. IIT Research Laboratories, Chicago, IllinoisGoogle Scholar
  103. 103.
    Williams TM, CattleyRC, Borghoff SJ (2000) Alterations in endocrine responses in male Sprague-Dawley rats following oral administration of methyl tert-butyl ether. Toxicol Sci 54:168–76CrossRefGoogle Scholar
  104. 104.
    Hard GC, Rodgers IS, Baetcke KP, Richards WL, McGaughyRE, Valcovic LR (1993) Hazard evaluation of chemicals that cause accumulation of α2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ Health Perspect 99:313–349Google Scholar
  105. 105.
    Borghoff SJ, Prescott JS, Janszen DB, Wong BA, EverittJI (2001) α2u-Globulin nephropathy, renal cell proliferation, and dosimetry of inhaled tert-butyl alcohol in male and female F-344 rats. Toxicol Sci 61:176–186CrossRefGoogle Scholar
  106. 106.
    RoyAK , McMinn DM, Biswas NM (1975) Estrogenic inhibition of the hepatic syn-thesis of α2u-globulin in the rat. Endocrinology 97:1501–1508CrossRefGoogle Scholar
  107. 107.
    Swenberg JA, Dietrich DR (1991) Immunochemical Localization of alpha-2u-Globulin in Kidneys of Treated and Control Rats of a 13-Week Vapor Inhalation Study with Methyl Tertiary Butyl Ether (MTBE). University of North Carolina, pp 1–5Google Scholar
  108. 108.
    Prescott-Mathews JS, Poet TS, Borghoff SJ (1999) Evaluation of the in vivo interac-tion of methyl tert-butyl ether with a2u-globulin in male F-344 rats. Toxicol Appl Pharmacol pp 60–67Google Scholar
  109. 109.
    Poet TS, Borghoff SJ (1997) In vitro uptake of methyl tert-butyl ether in male rat kidney: use of a two-compartment model to describe protein interactions. Toxicol Appl Pharmacol 145:340–348CrossRefGoogle Scholar
  110. 110.
    Williams TM, Borghoff SJ (2001) Characterization of tert-butyl alcohol binding to α2u-globulin in F-344 rats. Toxicol Sci 62:228–235CrossRefGoogle Scholar
  111. 111.
    Hess RA (1990) Quantitative and qualitative characteristics of the stages and transi-tions in the cycle of the rat seminiferous epithelium: light microscopic observations of perfusion-fixed and plastic-embedded testes. Biol Reprod 43:525–542CrossRefGoogle Scholar
  112. 112.
    Zhou W, YeS (1999) Subchronic Oral Methyl Tertiary Butyl Ether (MTBE) Exposure in Male Sprague-Dawley Rats and Effects on Health of MTBE Exposed Workers. J Occup Health 41:33–38CrossRefGoogle Scholar
  113. 113.
    de Peyster A, MacLean KJ, Stephens BA, Ahern LD, Westover CM, Rozenshteyn D (2003) Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer. Toxicol Sci 72:31–42CrossRefGoogle Scholar
  114. 114.
    MoserGJ , Wong BA, Wolf DC, Moss WR, Goldsworthy TL (1996b) Comparative short-term effects of methyl tertiary butyl ether and unleaded gasoline vapor in female B6C3F1 mice. Fundam Appl Pharmacol 31:173–183CrossRefGoogle Scholar
  115. 115.
    Moser GJ , Wong BA, Wolf DC, Fransson-Steen RL, Goldsworthy TL (1996) Methyl tertiary butyl ether lacks tumor-promoting activity in N-nitrosodiethylamine- initiated B6C3F1 female mouse liver. Carcinogenesis 17:2753–2761CrossRefGoogle Scholar
  116. 116.
    Hill RN, Erdreich LS, Paynter OE, Roberts PA, Rosenthal SL, Wilkinson CF (1989) Thyroid follicular carcinogenesis. Fund Appl Toxicol 12:629–697CrossRefGoogle Scholar
  117. 117.
    McClain RM (1989) The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia. Toxicol Pathol 17:294–306CrossRefGoogle Scholar
  118. 118.
    NEDO (New Energy Development Organization) (1987) Toxicological Research of Methanol as a Fuel for Power Station. NEDO, Tokyo, p 296Google Scholar
  119. 119.
    Innes JRM, Garner FM, StokeyJL (1967) Respiratory disease in rats. In: Cotchin E, Roe FJC (eds) Pathology of Laboratory Rats and Mice. Blackwell Scientific Publications, Oxford, pp 229–257Google Scholar
  120. 120.
    Nelson JB (1967) Respiratory infections of rats and mice with emphasis on indige-nous mycoplasms. In: Cotchin E, Roe FJC (eds) Pathology of Laboratory Rats and Mice. Blackwell Scientific Publications, Oxford, pp 259–294Google Scholar
  121. 121.
    Swaen GJV, van Heerde P (1973) Tumours of the haematopoietic system. In: Turusov VS (ed) Pathology of Tumours in Laboratory Animals, Vol I—Tumours of the Rat, Part 1. International Agency for Research on Cancer, Lyon, pp 185–201Google Scholar
  122. 122.
    Anderson JR (1985) In: Anderson JR (ed) Muir’s Textbook of Pathology, 12th edn. Edward Arnold, LondonGoogle Scholar
  123. 123.
    Moser GJ, Wolf DC, Sar M, Gaido KW, Janszen D, Goldsworthy TL (1998) Methyl tertiary butyl ether-induced endocrine alterations in mice are not mediated through the estrogen receptor. Toxicol Sci 41:77–87CrossRefGoogle Scholar
  124. 124.
    Bergendahl M, Perheentupa A, Huhtanieme I (1989) Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male rats. J Endocrinol 121:409–417CrossRefGoogle Scholar
  125. 125.
    Biles RW, Schroeder RE, Holdsworth CE (1987) Methyl tertiary butyl ether inhalation in rats: a single generation reproduction study. Toxicol Ind Health 3:519–533Google Scholar
  126. 126.
    Bevan C, Neeper-Bradley TL, Tyl RW, Fisher LC, Panson RD, Kneiss JJ, Andrews LS (1997a) Two-generation reproductive toxicity study of methyl tertiary-butyl ether (MTBE) in rats. J Appl Toxicol 17(1):13–19CrossRefGoogle Scholar
  127. 127.
    Conaway CC, Schroeder RE, Snyder NK (1985) Teratology evaluation of methyl ter-tiary butyl ether in rats and mice. J Toxicol Environ Health 16:797–809CrossRefGoogle Scholar
  128. 128.
    Bevan C, Tyl RW, Neeper-Bradley L, Fisher LC, Panson RD, Douglas JF, Andews LS (1997b) Developmental toxicity evaluation of methyl tertiary-butyl ether (MTBE) by inhalation in mice and rabbits. J Appl Toxicol 17(1):21–29CrossRefGoogle Scholar
  129. 129.
    DoddDE, Kintigh WJ (1989) Methyl Tertiary Butyl Ether (MTBE): Repeated (13- week) Vapor Inhalation Study in Rats with Neurotoxicity Evaluation. Bushy Run Research Center, Union Carbide Corp, Export, PennsylvaniaGoogle Scholar
  130. 130.
    Burleigh-Flayer HD, Chun JS, Kintigh WJ (1992) Methyl teriary butyl ether: vapor inhalation oncogenicity study in CD-1 mice. Bushy Run Research Center, Export, PennsylvaniaGoogle Scholar
  131. 131.
    Maltoni C, Belpoggi F, Soffritti M, Minardi F (1999) Comprehensive long-term ex-perimental project of carcinogenicity bioassays on gasoline oxygenated additives: plan and first report of results from the study on ethyl-tertiary-butyl ether (ETBE). Eur J Oncol 4:493–508Google Scholar
  132. 132.
    Hard GC (2006) Expert Review of Kidney Histopathology in the 2-Year Carcino-genicity Study of Methyl Tert Butyl Ether (MTBE) Administered to Fischer 344 Rats by Vapor Inhalation, 18 pp, prepared for Lyondell Chemical Company, Houston TX, USA. Submitted to Dr. Abel-Razak Kadry, Program Director, Integrated Risk Information System (IRIS), National Center for Environmental Assessment US En-vironmental Protection Agency, Ariel Rios Federal Building, 1200 Pennsylvania Av. N.W., Washington, DC 20460Google Scholar
  133. 133.
    Soffritti M, Belpoggi F, Cevolani D, Guarino M, Padovani M, Maltoni C (2002) Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Ann NY Acad Sci 982:46–69CrossRefGoogle Scholar
  134. 134.
    Borghoff SJ, Lagarde WH (1993) Assessment of binding of 2,4,4-trimethyl-2-pentanol to low-molecular-weight proteins isolated from kidneys of male rats and humans. Toxicol Appl Pharmacol 119:228–235CrossRefGoogle Scholar
  135. 135.
    US EPA (1991) Alpha 2u-globulin: Association with chemically induced renal tox-icity and neoplasia in the male rat. Risk Assessment Forum, US Environmental Protection Agency, Washington, DC, EPA/625/3-91/019F, pp 1–132Google Scholar
  136. 136.
    IARC (1999b) Consensus Report. In: Capen CC, Dybing E, Rice JM, Wilbourn JD (eds) Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, pp 5-9. IARC Sci Pub No 147. International Agency for Research on Cancer, Lyon, FranceGoogle Scholar
  137. 137.
    Swenberg JA, Lehman-McKeeman LD (1999) α2-Urinary globulin associated nephro-pathy as a mechanism of renal tubule cell carcinogenesis in male rats. In: Capen CC, Dybing E, Rice JM, Wilbourn JD (eds) Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, pp 5-9. IARC Sci Pub No. 147. International Agency for Research on Cancer, Lyon, FranceGoogle Scholar
  138. 138.
    Hard GC, Khan KN (2004) A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol Pathol 32:171–80CrossRefGoogle Scholar
  139. 139.
    Frocht A, Fillit H (1984) Renal disease in the geriatric patient. J Am Geriatrics Soc 32:28–43Google Scholar
  140. 140.
    Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remissionm regression of chronic renal diseases. Lancet 357:1601–1608CrossRefGoogle Scholar
  141. 141.
    Coleman GL, BartholdSW, Osbaldiston GW, Foster SJ, Jonas AM (1977) Pathologi-cal changes during aging in barrier-maintained Fischer 344 male rats. J Gerontol 32:258–278CrossRefGoogle Scholar
  142. 142.
    Ueberberg H, Lutzen L (1979) The spantaneous rate of tumours in the laboratory rat: strain Chbb:THOM (SPF). Drug Res 29:876–1879Google Scholar
  143. 143.
    Anver MR, Cohen BJ, Lattuada CP, Foster SJ (1982) Age-associated lesions in barriertreated male Sprague-Dawley rats: A comparison between HapSD) and Crl:COBS CD (SD) stocks. Exp Aging Res 8:3–24CrossRefGoogle Scholar
  144. 144.
    Deerberg F, Rapp KG, Rehm S (1982) Mortality and pathology of Han: Wist rats depending on age and genetics. Expl Biol Med 7:63–71Google Scholar
  145. 145.
    Haseman JK (1983) A reexamination of false-positive rates for carcinogenesis stud-ies. Fundam Appl Toxicol 3:334–339CrossRefGoogle Scholar
  146. 146.
    Haseman JK, HaileyJR, Morris RW (1998) Spontaneous neoplasm incidences in Fischer-344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol 26:428–441CrossRefGoogle Scholar
  147. 147.
    Cook JC, Klinefelter GR, HardistyJF, Sharpe RM, Foster MD (1999) Rodent Leydig Cell Tumorigenesis: A review of the Physiology, Pathology, Mechanisms, and Rele-vance to Humans. Crit Rev Toxicol 29:169–261CrossRefGoogle Scholar
  148. 148.
    Huhtaniemi IT (1983) Gonadotrophin receptors: correlates with normal and pathological functions of the human ovary and testis. In: Clayton WB (ed), Clinical En-docrinology and Metabolism: Receptors in Health and Disease. Saunders, Philadelphia, pp 117–132Google Scholar
  149. 149.
    Christensen AK, Peacock KC (1980) Increase in Leydig cell number in testes of adult rats treated chronologically with an excess of hCG. Biol Reprod 22:383–391Google Scholar
  150. 150.
    Heller C, Leach D (1971) Quantification of Leydig cells and measurement of Leydig cell size following administration of human chorionic gonadotrophin to normal men. J Reprod Fertil 25:185–192CrossRefGoogle Scholar
  151. 151.
    Simpson BJB, Wu FCW, Sharpe RM (1987) Isolation of human Leydig cells which are highly responsive to hCG. J Clin Endocrinol Metab 65:415–422CrossRefGoogle Scholar
  152. 152.
    Clayton RM, Huhtaniemi IT (1982) Absence of gonadotropin-releasing hormone re-ceptors in human gonadal tissue. Nature 299:56–59CrossRefGoogle Scholar
  153. 153.
    Wang N-G, Sundaram K, Pavlou S, Rivier J, Vale W, Bardin CW (1983) Mice are in-sensitive to the anti-testicular effects of luteinizing hormone-releasing hormone agonists. Endocrinology 112:331–335CrossRefGoogle Scholar
  154. 154.
    Bar A (1992) Significance of Leydig cell neoplasia in rats fed lactitol or lactose. J Am Coll Toxicol 11:189–207CrossRefGoogle Scholar
  155. 155.
    Prentice DE, Meikle AW (1995) A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man. Human Exp Toxicol 14:562–572CrossRefGoogle Scholar
  156. 156.
    BoslandMC (1996) Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. In: Huff J, Boyd J, Barett JC (eds) Cellular and Mo-lecular Mechanisms of Hormonal Carcinogenesis: Environmental influences. Wiley- Liss, New York, pp 309–352Google Scholar
  157. 157.
    Fort FL, Miyajima H, Ando T, Suzuki T, Yamamoto M, Hamashima T, Sato S, Kitazi T, Mahony MC Hodgen GD (1995) Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole. Fund Appl Toxicol 26:191–202CrossRefGoogle Scholar
  158. 158.
    CookJC , MullinLS , Frame SR, Biegel LB (1993) Investigation of a mechanism for Leydig cell tumorigenesis by Linuron in rats. Toxicol Appl Pharmacol 119:195–204CrossRefGoogle Scholar
  159. 159.
    Neuman F (1991) Early indictors for carcinogenicity in sex-hormone sensitive organs. Mutat Res 248:341–356CrossRefGoogle Scholar
  160. 160.
    Murakami M, HosokawaS, YamadaT, HarakawaM, Ito M, KoyamaY, KimuraJ, Yoshitake A, Yamada H (1995) Species-specific mechanism in rat Leydig cell tumoriogenesis by procymidone. Toxicol Appl Pharmacol 131:244–252CrossRefGoogle Scholar
  161. 161.
    CleggED , CookJC , Chapin RE, Foster PM, Daston GP (1997) Leydig cell hyperplasia and adenoma formation: Mechanisms and relevance to humans. Reprod Toxicol 11:107–121CrossRefGoogle Scholar
  162. 162.
    O’Conner JC, Cook JC, Slone TW, Makovec T, Frame SR, Davis LG (1998) An ongoing validation of a Tier 1 screening battery for detecting endocrine-active compounds (EACs). Toxicol Sci 46:45–80CrossRefGoogle Scholar
  163. 163.
    Prentice DE, Siegel RA, Donatsch P, Qureshi S, Ettlin RA (1992) Mesulergine induced Leydig cell tumours, a syndrome involving the pituitary-testicular axis of the rat. Arch Toxicol 15:197–204CrossRefGoogle Scholar
  164. 164.
    Cook JC, Murray SM, Frame SR, Hurtt ME (1992) Induction of Leydig cell adenomas by ammonium perflurooctanoate: A possible endocrine-related mechanism. Toxicol. Appl Pharmacol 113:209–217CrossRefGoogle Scholar
  165. 165.
    Liu RCM, Hahn C, Hurtt ME (1996) The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro. Fund Appl Toxicol 30:102–108CrossRefGoogle Scholar
  166. 166.
    Fitzgerald JE, Sanyer JL, Schardein JL, Lake RS, McGuire EJ, de la Iglesia FA (1981) Carcinogen bioassay and mutagenicity studies with the hypolipdemic agent gemfi-brozil. J Natl Cancer Inst 67:1105–1116Google Scholar
  167. 167.
    Maltoni C, Lefemine G, Cotti G, Perino G (1988) Long-term carcinogenic bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice. Ann NY Acad Sci 534:316–351CrossRefGoogle Scholar
  168. 168.
    NTP National Toxicology Program (1990) Toxicology and Carcinogenesis Studies of d-Limonene in F344/N Rats and B6C3F1 Mice (Tech. Rep. Ser. No. 347; NIH Publ. No. 90-2802), Research Triangle Park, NCGoogle Scholar
  169. 169.
    Bruner RH, Kinkead ER, O’Neill TP, Flemming CD, Mattie DR, Russell CA, Wall HG (1993) The toxicologic and oncogenic potential of JP-4 nmjet fuel vapors in rats and mice: 12-month intermittent inhalation exposures. Fundam Appl Toxicol 20:97–110CrossRefGoogle Scholar
  170. 170.
    PDR (1998) Physician’s Desk Reference 52nd ed. Medical Economics Company, Montvale, NJGoogle Scholar
  171. 171.
    ShimkinMB , Grady HG, Andervont HB (1941) Induction of testicular tumors and other effects of stilbestrol-cholesterol pellets in strain C mice. J Natl Cancer Inst 2:65–880Google Scholar
  172. 172.
    Bonser GM (1942) Malignant tumours of the interstitial cells of the testis in Strong A mice treated with triphenylethylene. J Pathol Bacteriol 54:149–154CrossRefGoogle Scholar
  173. 173.
    Gardner WU, Boddaert J (1950) Testicular interstitial cell tumors in hybrid mice given tri-p-anisyl chloroethylene. Arch Pathol, pp 750–764Google Scholar
  174. 174.
    Baroni C, Magrini U, Martinazzi M, Bertoli G (1966) Testicular Leydig cell tumourigenesis by diethylstilbestrol in the BALB/c mouse. Histologic and histochemical study. Eur J Cancer 2:211–220CrossRefGoogle Scholar
  175. 175.
    Reuber MD (1979) Interstitial cell carcinomas of the testis in Balb/C mace mice ingesting methoxychlor. J Cancer Res Clin Oncol 93:173–179CrossRefGoogle Scholar
  176. 176.
    Huseby RA (1980) Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse. Cancer Res 40:1006–1013Google Scholar
  177. 177.
    Tucker MJ, Adam HK, Patterson JS (1984) Tamoxifen. In: Tucker MJ, Adams HK (eds) Safety Testing of New Drugs. Laboratory Predictions and Clinical Performance. Academic Press, London, pp 125–161Google Scholar
  178. 178.
    Newbold RR, Bullock BC, McLachlan JA (1987) Testicular tumors in mice exposed in utero to diethylstilbestrol. J Urol 138:1446–1450Google Scholar
  179. 179.
    Geaves P, Goonetilleke R, Nunn G, Topham J, Orton T (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res 53:3919–3924Google Scholar
  180. 180.
    PrahalandaS , MajkaJA , Soper KA, Nett TM, Bagdon WJ, Peter CP, BurekJD , Mac- Donald JS, Van ZwietenMJ (1994) Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5α-reductase inhibitor: a possible mechanism. Fundam Appl Toxicol 22:211–219CrossRefGoogle Scholar
  181. 181.
    ClappNK (1973) Carcinogenicity of nitrosamines and methanesulphonate esters given intraperitoneally in RF mice. Int J Cancer 12:728–733CrossRefGoogle Scholar
  182. 182.
    Reznik-Schuller H (1979) Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. J Natl Cancer Inst 62:1083–1088Google Scholar
  183. 183.
    BartkeA , Sweeney CA, Johnson L, Castracane VD, DohertyPC (1985) Hyperprolactinemia inhibits development of Leydig cell tumors in aging Fischer rats. Exp Aging Res 11:123–127CrossRefGoogle Scholar
  184. 184.
    Yasuda Y, Konishi H, TanimuraT (1986) Leydig cell hyperplasia in fetal mice treated transplacentally with ethinyl estradiol. Teratology 33:281–288CrossRefGoogle Scholar
  185. 185.
    Walker AH, Bernstein L, Warren DW, Warner NE, Zheng X, Henderson BE (1990) The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice. Br J Cancer 62:599–602CrossRefGoogle Scholar
  186. 186.
    Huseby RA (1981) Effects of cryptorchidy, parabiosis, and estrogen administration upon Leydig cell tumorigenesis in Fischer rats. Cancer Res 41:3172–3178Google Scholar
  187. 187.
    Sato B, SpomerW, Huseby RA, Samuels LT (1979) The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors. Endocrinology 104:822–831CrossRefGoogle Scholar
  188. 188.
    Fowler KA, Gill K, KirmaN, Dillehay DL, Tekmal RR (2000) Overexpression of aromatase leads to development of testicular leydig cell tumors: an in vivo model for hormone-mediated Testicular Cancer. Am J Pathol 156:347–353CrossRefGoogle Scholar
  189. 189.
    HomburgerF , RussfieldAB , Weisburger JH, Lim S, ChakSP , Weisburger EF (1975) Aging changes in CD®-1 HaM/ICR mice reared under standard laboratory condi-tions. J Natl Cancer Inst 55:37–45Google Scholar
  190. 190.
    Bomhard E, Mohr U (1989) Spomtaneous tumors in NMRI mice from carcinogenisity studies. Exp Pathol 36:129–145CrossRefGoogle Scholar
  191. 191.
    Maltoni C, Cotti G, Patella V (1986) Results of long-term carcinogenicity bioassays on Sprague-Dawley rats of methyl chloroform, administered by ingestion. Acta On-col 7:101–117Google Scholar
  192. 192.
    Cotti G, Maltoni C, Lefemine G (1988) Long-term carcinogenicity bioassay on vinylidene chloride administered by inhalation to Sprague-Dawley rats. Ann NY Acad Sci 534:160–168CrossRefGoogle Scholar
  193. 193.
    Belpoggi F, Soffritti M, Minardi F, Bua L, Cattin E, Maltoni C (2002) Results of Long- term carcinogenicity bioassays on tert-amyl-methyl ether (TAME) and di-isopropyl- ether (DIPE) in rats. Ann NY Acad Sci 982:70–86CrossRefGoogle Scholar
  194. 194.
    Sinkeldam EJ, Kuper CF, Beems RB, Newman AJ, Feron VJ (1991) Combined chronic toxicity and carcinogenicity study with acesulfame-K in rats. In: Mayer DG, Kemper FH (eds) Acesulfame-K. Marcel Dekker, New York, pp 43–58Google Scholar
  195. 195.
    Feron VJ, Til HP, Woutersen RA (1990) Letter to the Editor. Toxicol Ind Health 6:637–639Google Scholar
  196. 196.
    Williams-Hill D, Spears CP, Prakash S, Olah GA, Shamma T, Moin T, Kim LK, Hill CK (1999) Mutagenicity studies of methyl-tert-butylether using the Ames tester strain TA102. Mutat Res 446:15–21CrossRefGoogle Scholar
  197. 197.
    McGregor DB, Cruzan G, Callander RD, MayK, Banton M (2005) The mutagenicity testing of tertiary-butyl alcohol, tertiary-butyl acetate, and methyl tertiary-butyl ether in Salmonella typhimurium. Mutat Res 565:181–189CrossRefGoogle Scholar
  198. 198.
    Budroe JD, Brown JP, Salsmon AG, Marty MA (2004) Acute toxicity and cancer risk assessment values for tert-butyl acetate. Reg Toxicol Pharmacol 40:168–176CrossRefGoogle Scholar
  199. 199.
    Dillon D, Coombes R, Zeiger E (1998) The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides. Mutagenesis 1319–36Google Scholar
  200. 200.
    FialaES, ConawayCC, Biles WT and Johnson B (1987) Enhanced Mutagenicity of 2-Nitropropane Nitronate with Respect to 2-Nitropropane Possible Involvement of Free Radical Species. Mutat Res 179:15–22CrossRefGoogle Scholar
  201. 201.
    Panganamala RV, SharmaHM, Heikkila RE, Geer JC, Cornwell DG (1976) Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols, and methional in the inhi-bition of prostaglandin biosynthesis. Prostaglandins 11:599–607CrossRefGoogle Scholar
  202. 202.
    Roots R, Okada S (1972) Protection of DNA molecules of cultured mammalian cells from radiation-induced single-strand scissions by various alcohols and syulfhydryl compounds. Int J Radiat Biol 21:329–342CrossRefGoogle Scholar
  203. 203.
    Reuvers AP, Greenstock CL, Borsa J, Chapman JD (1973) Mechanism of chemical radioprotection by dimethyl sulfoxide. Int J Radiat Biol 24:533–536CrossRefGoogle Scholar
  204. 204.
    LaFleur MV, Loman H (1982) Influence of anoxic sensitizers on the radiation damage in biologically activeDNAin aqueous solution. Int J Radiat Biol 41:295–302CrossRefGoogle Scholar
  205. 205.
    Mackerer CR, Angelosanto FA, Blackburn GR, Schreiner CA (1996) Identification of formaldehyde as the metabolite responsible for the mutagenicity of methyl tertiary- butyl ether in the activated mouse lymphoma assay. Proc Soc Exp Biol Med 212:338–341CrossRefGoogle Scholar
  206. 206.
    McGregor DB, Edwards I, Riach CG, Cattanach P, Martin R, Mitchell A, Caspary WJ (1988a) Studies of an S9-based metabolic activation system used in the mouse lym-phoma L5178Y cell mutation assay. Mutagenesis 3:485–490CrossRefGoogle Scholar
  207. 207.
    McGregor DB, Martin R, Cattanach P, Edwards I, McBride D, Caspary WJ (1988b) Responses of the L5178Y tk+tk- mouse lymphoma cell forward mutation assay. II: 18 Chemicals. Environ Mol Mutagen 11:91–118CrossRefGoogle Scholar
  208. 208.
    Litton Bionetics (1978) Mutagenicity evaluation of TBME-95 in the Ames Salmonella/ microsome plate test. Litton Bionetics, Kensington, MarylandGoogle Scholar
  209. 209.
    Life Science Research (1989) Reverse mutation in Salmonella typhimurium, test sub-stance: MtBE. Report No. 216002-M-03489. Life Science Research, Roma Toxicology Centre, S.P.A.R.K, Rome, ItalyGoogle Scholar
  210. 210.
    Hüls (1991) Bestimmung der Mutagenitäts von DRIVERON im Salmonella/Säuger- Mikrosomen-Mutagenitätstest nach Ames Mutagenitätstest nach Richtlinie 84/449/EWG B,14. pp 24. Hüls, MarlGoogle Scholar
  211. 211.
    RBM (1996e) Study of the ability of the test article MTBE to induce gene mutation in strains of Salmonella typhimurium. Instituto di Ricerche Biomediche ’Antoine Marxer’ RBM S.p.A, Rome, ItalyGoogle Scholar
  212. 212.
    Kado NY, Kuzmicky PA, Loarca-Pina GL, Mumtaz MM (1998) Genotoxicity testing of methyl tertiary-butyl ether (MTBE) in the Salmonella microsuspension assay and mouse bone marrow micronucleus test. Mutat Res 412:131–138CrossRefGoogle Scholar
  213. 213.
    Zhou W, YuanD, Huang G, Zhang H, Ye S (2000) Mutagenicity of methyl tertiary butyl ether. J Environ Pathol Oncol 16:35–39Google Scholar
  214. 214.
    McKee RH, Vergnes JS, Galvin JB, Douglas JR, Kneiss JJ, Andrews LS (1997) Assess-ment of the in vivo mutagenic potential of methyl tertiary–butyl ether. J Appl Toxicol 17:31–36CrossRefGoogle Scholar
  215. 215.
    Tang G, Wang J, Zhuang Z (1997) Cytotoxicity and genotoxicity of methyl tert-butyl ether and its metabolite in human leukaemia cells. Clin J Prev Med 31:334–337Google Scholar
  216. 216.
    Life Science Research (1989) Unscheduled DNA Synthesis (UDS) in Primary Rat Hepatocytes (Autoradiographic Method), test substance:MtBE. Report No. 216003- M-03689. Life Science Research, Roma Toxicology Centre, S.P.A.R.K, Rome, ItalyGoogle Scholar
  217. 217.
    Cinelli S, Ciliutti P, Falezza A, Meli C, Caserta L, Marchetti S, Seeberg AH, Vericat JA (1992) Absence of mutagenicity of methyl-tertiary-butyl ether. Toxicol Lett (suppl): 300 (P36/P10)Google Scholar
  218. 218.
    Life Science Research (1989) Gene mutation in Chinese hamster V79 cells, test substance:MtBE. Report No. 216002-M-03589. Life Science Research, Roma Toxicology Centre, S.P.A.R.K, Rome, ItalyGoogle Scholar
  219. 219.
    Lee LC, Quintana PJE, de Peyster A (1998) Comet assay evaluation of the effect of methyl t-butyl ether (MTBE) on rat lymphocytes. The Toxicologist. 42(suppl):187 (abstract)Google Scholar
  220. 220.
    Ward JB, DalkerDH , Hastings DA, Ammenhauser MM, and Legator MS (1995) As-sessment of the mutagenicity of methyl tertiary butyl ether at the HPRT gene in CD-1 mice. The Toxicologist 15:79 Abstr. 415Google Scholar
  221. 221.
    Litton Bionetics (1979) Mutagenicity Evaluation of TBME 99% in the Rat Bone Mar-row Cytogenetic Analysis. Litton Bionetics, Kensington, MarylandGoogle Scholar
  222. 222.
    Institut Pasteur de Lille (1992b) Recherche de mutagenicity sur Salmonella ty-phimurium His selon la technique de BN Ames. Report IPL-R 920506 for Total Raffinage Distribution, 25 May 1992Google Scholar
  223. 223.
    Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K (1992) Salmonella Muta-genicity Tests: V. Results from the testing of 311 chemicals. Environ Mol Mutagen 19(21):2–141CrossRefGoogle Scholar
  224. 224.
    Pharmakon Europe (1994e) Test article: ETBE. Salmonella typhimurium/mammalian microsome plate incorporation assay (Ames test). Report No 76593 for Elf, 18 April 1994Google Scholar
  225. 225.
    Bushy Run Research Center (1995a) Ethyl tertiary butyl ether: mutagenic potential in the CHO/HGPRT forward mutation assay, unpublished study 94N1424 for ARCO Chemical Company PA, January 1995Google Scholar
  226. 226.
    Bushy Run Research Center (1995b) Ethyl tertiary butyl ether: in vitro Chromosome aberrations assay in Chinese Hamster Ovary Cells. Unpublished study 94N1425 for ARCO Chemical Company PA, January 1995Google Scholar
  227. 227.
    Institut Pasteur de Lille (1992c) Etude de l’activite genotoxique par la technique du micronucleus chez la souris sur le produit ether ETBE. Report IPL-R 921009 for Total Raffinage Distribution, 30 October 1992Google Scholar
  228. 228.
    Bushy Run Research Center (1995c) Ethyl tertiary butyl ether: bone marrow mi-cronucleus test in mice, unpublished study 94N1426 for ARCO Chemical Company PA, January 1995Google Scholar
  229. 229.
    Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W (1987) Salmo-nella mutagenicity tests. III. Results from the testing of 255 chemicals. Environ Mutagen 19(21):2–141Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • Douglas McGregor
    • 1
  1. 1.Toxicity Evaluation ConsultantsUK

Personalised recommendations